Ordering
Available Variants1 mg
CHA.68120-1mg
Price
€149.60
Available – Dispatch in 14 days
5 mg
CHA.68120-5mg
Price
€614.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 mg | CHA.68120-1mg | €149.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.68120-5mg | €614.40 |
≥95%
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C10H16N5O12P3 |
|---|---|
| CAS Number | 71997-32-5 |
| Molecular Weight | 491.18 |
| NACRES | NA.51 |
| PubChem Substance ID | 24893135 |
| UNSPSC Code | 41106305 |
| MDL number | MFCD00057015 |
| Assay | ≥95% |
| Form | powder |
| Quality level | 200 |
Safety Information Handling visibility
| pictograms |
GHS08
GHS07
  GHS08,GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 + H332,H315,H319,H335,H351 |
| pcodes | P202 - P301 + P312 - P302 + P352 - P304 + P340 + P312 - P305 + P351 + P338 - P308 + P313 |
| Hazard Classifications | Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| target_organs | Respiratory system |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| ppe | Eyeshields, Gloves, type P3 (EN 143) respirator cartridges |
Technical Overview & Applications Use-case context
Cordycepin 5′-triphosphate sodium salt, with the CAS number 71997-32-5, is a nucleotide derivative that has garnered significant attention in the scientific community due to its potential therapeutic applications. As a triphosphate derivative of cordycepin, it exhibits a range of biological activities, including antiviral, antibacterial, and antitumor properties. The sodium salt form of cordycepin 5′-triphosphate is highly soluble in water, making it a suitable candidate for various pharmaceutical formulations. Research has shown that this compound can inhibit the replication of certain viruses and exhibit cytotoxic effects on cancer cells, highlighting its potential as a novel therapeutic agent. Further studies are necessary to fully elucidate the mechanisms of action and potential clinical applications of cordycepin 5′-triphosphate sodium salt, but its unique properties make it an intriguing subject for ongoing scientific investigation.
